Stocks
Denali Therapeutics (DNLI) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -6.19 | 123.1 | -15.6 | -6.71 | -10.9 | -10.1 | ||
| Changes by years, y/y, % | -80% | -2 090% | -113% | -57% | +63% | -19.0% | |||
Denali Therapeutics. EV/EBITDA
Denali Therapeutics. EV/EBITDA, changes, %
Denali Therapeutics (DNLI) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EV/EBITDA | ? | -4.95 | -18.5 | -10.9 | -10.3 | -10.8 | -10.1 | |
| Changes by years, y/y, % | -55% | +99% | +21% | +41% | +118% | |||
| Changes by quarters, q/q, % | -32% | +275% | -41% | -6% | +5% | |||
